In comparison to previous studies, the STXBP1 participant group had a higher proportion of individuals ascertained via clinical genetics rather than paediatric neurology, which may provide a more comprehensive picture of the phenotypic spectrum or may under-represent individuals with early-onset epileptic encephalopathy. This evidence concerns the gene STXBP1 and Epileptic encephalopathy.